Figure 3 | Scientific Reports

Figure 3

From: Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patients

Figure 3

Diagnostic and Prognostic value of serum and CSF markers. High serum glutamate levels at days 5–7 correlated with higher HH (A). Serum glutamate levels at days 0–3, 5–7, and 14 post-SAH correlated with the presence of ischemia (hypodense lesions) on a brain CT scan (B) and increased intracranial pressure (ICP) (C). (D-F) Correlation between serum glutamate levels at days 0–3, 5–7, and 14 post-SAH and presence of neurological deficits at discharge (D), clinical outcome defined as “good” (GOS IV–V) versus “poor” (GOS I–III) 3 months after SAH (E), and hospital length of stay (LOS) (F). Data are expressed as the median and interquartile range. Statistical analysis was performed using the Mann Whitney test, *p < 0.05, **p < 0.01.

Back to article page